Brief: Tricida Announces Updates On Veverimer Development Program

Tricida

08/12/2020 21:43

Dec 8 (Reuters) - Tricida Inc  TCDA.O :
    * TRICIDA ANNOUNCES UPDATES ON VEVERIMER DEVELOPMENT
PROGRAM,
REGULATORY STATUS AND NEW PATENT EXTENDING PROTECTION THROUGH
2038
    * TRICIDA INC - HAS REVISED PROTOCOL FOR ITS VALOR-CKD
OUTCOME
TRIAL
    * TRICIDA INC - A FDRR HAS BEEN SUBMITTED TO FDA TO SEEK
CLARITY
ON PATH FORWARD FOR RESUBMITTING NDA THROUGH ACCELERATED
APPROVAL PROGRAM
    * TRICIDA INC - DECISION ON FDRR IS EXPECTED IN Q1 OF 2021
    * TRICIDA INC - TIMING AND NEXT STEPS FOR A RESUBMISSION OF
NDA
FOR VEVERIMER WILL BE DEPENDENT UPON OND'S DECISION
    * TRICIDA INC - CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF
SEPTEMBER 30, 2020 WERE APPROXIMATELY $376 MILLION
    * TRICIDA INC - CURRENTLY HAS FINANCIAL RESOURCES TO FUND
OUR
OPERATIONS INTO AT LEAST MID-2022, PRIOR TO MODIFYING ANY OF ITS
MATERIAL AGREEMENTS

Source text for Eikon:  ID:nGNXbTMbP0 
Further company coverage:  TCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))